SPHINGOGLYCOLIPID ANALOGUES AS THERAPEUTIC AGENTS

This invention relates to sphingoglycolipid analogues of formula CN145: OH CN145 HO < - 0 n r 0 0 tail N Ci5115,4= compositions comprising these compounds, processes for preparing the compounds, and methods of treating or preventing diseases or conditions using the compounds, such as diseases or...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: HERMANS, IAN FRANCIS, ANDERSON, REGAN JAMES, LARSEN, DAVID SAMUEL, HAYMAN, COLIN MALCOLM, COMPTON, BENJAMIN JASON, PAINTER, GAVIN FRANK
Format: Patent
Sprache:eng ; fre
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator HERMANS, IAN FRANCIS
ANDERSON, REGAN JAMES
LARSEN, DAVID SAMUEL
HAYMAN, COLIN MALCOLM
COMPTON, BENJAMIN JASON
PAINTER, GAVIN FRANK
description This invention relates to sphingoglycolipid analogues of formula CN145: OH CN145 HO < - 0 n r 0 0 tail N Ci5115,4= compositions comprising these compounds, processes for preparing the compounds, and methods of treating or preventing diseases or conditions using the compounds, such as diseases or conditions relating to infection, atopic disorders, autoimmune disease, diabetes or cancer. Date Recue/Date Received 2020-06-05 La présente invention concerne des analogues de glycosphingolipide, des compositions comprenant ces composés, des procédés de préparation des composés, et des méthodes de traitement ou de prévention de maladies ou d'états faisant intervenir ces composés, tels que des maladies ou des états associés à une infection, des troubles atopiques, une maladie auto-immune, un diabète ou un cancer.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CA2880191C</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CA2880191C</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CA2880191C3</originalsourceid><addsrcrecordid>eNrjZDAMDvDw9HP3d_eJdPb38QzwdFFw9HP08XcPdQ1WcAxWCPFwDXIMcA0N8XRWcHR39QsJ5mFgTUvMKU7lhdLcDPJuriHOHrqpBfnxqcUFicmpeakl8c6ORhYWBoaWhs7GhFUAAOCeJfM</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>SPHINGOGLYCOLIPID ANALOGUES AS THERAPEUTIC AGENTS</title><source>esp@cenet</source><creator>HERMANS, IAN FRANCIS ; ANDERSON, REGAN JAMES ; LARSEN, DAVID SAMUEL ; HAYMAN, COLIN MALCOLM ; COMPTON, BENJAMIN JASON ; PAINTER, GAVIN FRANK</creator><creatorcontrib>HERMANS, IAN FRANCIS ; ANDERSON, REGAN JAMES ; LARSEN, DAVID SAMUEL ; HAYMAN, COLIN MALCOLM ; COMPTON, BENJAMIN JASON ; PAINTER, GAVIN FRANK</creatorcontrib><description>This invention relates to sphingoglycolipid analogues of formula CN145: OH CN145 HO &lt; - 0 n r 0 0 tail N Ci5115,4= compositions comprising these compounds, processes for preparing the compounds, and methods of treating or preventing diseases or conditions using the compounds, such as diseases or conditions relating to infection, atopic disorders, autoimmune disease, diabetes or cancer. Date Recue/Date Received 2020-06-05 La présente invention concerne des analogues de glycosphingolipide, des compositions comprenant ces composés, des procédés de préparation des composés, et des méthodes de traitement ou de prévention de maladies ou d'états faisant intervenir ces composés, tels que des maladies ou des états associés à une infection, des troubles atopiques, une maladie auto-immune, un diabète ou un cancer.</description><language>eng ; fre</language><subject>CHEMISTRY ; DERIVATIVES THEREOF ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; NUCLEIC ACIDS ; NUCLEOSIDES ; NUCLEOTIDES ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS ; SUGARS</subject><creationdate>2021</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20210420&amp;DB=EPODOC&amp;CC=CA&amp;NR=2880191C$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25562,76317</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20210420&amp;DB=EPODOC&amp;CC=CA&amp;NR=2880191C$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>HERMANS, IAN FRANCIS</creatorcontrib><creatorcontrib>ANDERSON, REGAN JAMES</creatorcontrib><creatorcontrib>LARSEN, DAVID SAMUEL</creatorcontrib><creatorcontrib>HAYMAN, COLIN MALCOLM</creatorcontrib><creatorcontrib>COMPTON, BENJAMIN JASON</creatorcontrib><creatorcontrib>PAINTER, GAVIN FRANK</creatorcontrib><title>SPHINGOGLYCOLIPID ANALOGUES AS THERAPEUTIC AGENTS</title><description>This invention relates to sphingoglycolipid analogues of formula CN145: OH CN145 HO &lt; - 0 n r 0 0 tail N Ci5115,4= compositions comprising these compounds, processes for preparing the compounds, and methods of treating or preventing diseases or conditions using the compounds, such as diseases or conditions relating to infection, atopic disorders, autoimmune disease, diabetes or cancer. Date Recue/Date Received 2020-06-05 La présente invention concerne des analogues de glycosphingolipide, des compositions comprenant ces composés, des procédés de préparation des composés, et des méthodes de traitement ou de prévention de maladies ou d'états faisant intervenir ces composés, tels que des maladies ou des états associés à une infection, des troubles atopiques, une maladie auto-immune, un diabète ou un cancer.</description><subject>CHEMISTRY</subject><subject>DERIVATIVES THEREOF</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>NUCLEIC ACIDS</subject><subject>NUCLEOSIDES</subject><subject>NUCLEOTIDES</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><subject>SUGARS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2021</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDAMDvDw9HP3d_eJdPb38QzwdFFw9HP08XcPdQ1WcAxWCPFwDXIMcA0N8XRWcHR39QsJ5mFgTUvMKU7lhdLcDPJuriHOHrqpBfnxqcUFicmpeakl8c6ORhYWBoaWhs7GhFUAAOCeJfM</recordid><startdate>20210420</startdate><enddate>20210420</enddate><creator>HERMANS, IAN FRANCIS</creator><creator>ANDERSON, REGAN JAMES</creator><creator>LARSEN, DAVID SAMUEL</creator><creator>HAYMAN, COLIN MALCOLM</creator><creator>COMPTON, BENJAMIN JASON</creator><creator>PAINTER, GAVIN FRANK</creator><scope>EVB</scope></search><sort><creationdate>20210420</creationdate><title>SPHINGOGLYCOLIPID ANALOGUES AS THERAPEUTIC AGENTS</title><author>HERMANS, IAN FRANCIS ; ANDERSON, REGAN JAMES ; LARSEN, DAVID SAMUEL ; HAYMAN, COLIN MALCOLM ; COMPTON, BENJAMIN JASON ; PAINTER, GAVIN FRANK</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CA2880191C3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2021</creationdate><topic>CHEMISTRY</topic><topic>DERIVATIVES THEREOF</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>NUCLEIC ACIDS</topic><topic>NUCLEOSIDES</topic><topic>NUCLEOTIDES</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><topic>SUGARS</topic><toplevel>online_resources</toplevel><creatorcontrib>HERMANS, IAN FRANCIS</creatorcontrib><creatorcontrib>ANDERSON, REGAN JAMES</creatorcontrib><creatorcontrib>LARSEN, DAVID SAMUEL</creatorcontrib><creatorcontrib>HAYMAN, COLIN MALCOLM</creatorcontrib><creatorcontrib>COMPTON, BENJAMIN JASON</creatorcontrib><creatorcontrib>PAINTER, GAVIN FRANK</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>HERMANS, IAN FRANCIS</au><au>ANDERSON, REGAN JAMES</au><au>LARSEN, DAVID SAMUEL</au><au>HAYMAN, COLIN MALCOLM</au><au>COMPTON, BENJAMIN JASON</au><au>PAINTER, GAVIN FRANK</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>SPHINGOGLYCOLIPID ANALOGUES AS THERAPEUTIC AGENTS</title><date>2021-04-20</date><risdate>2021</risdate><abstract>This invention relates to sphingoglycolipid analogues of formula CN145: OH CN145 HO &lt; - 0 n r 0 0 tail N Ci5115,4= compositions comprising these compounds, processes for preparing the compounds, and methods of treating or preventing diseases or conditions using the compounds, such as diseases or conditions relating to infection, atopic disorders, autoimmune disease, diabetes or cancer. Date Recue/Date Received 2020-06-05 La présente invention concerne des analogues de glycosphingolipide, des compositions comprenant ces composés, des procédés de préparation des composés, et des méthodes de traitement ou de prévention de maladies ou d'états faisant intervenir ces composés, tels que des maladies ou des états associés à une infection, des troubles atopiques, une maladie auto-immune, un diabète ou un cancer.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; fre
recordid cdi_epo_espacenet_CA2880191C
source esp@cenet
subjects CHEMISTRY
DERIVATIVES THEREOF
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
NUCLEIC ACIDS
NUCLEOSIDES
NUCLEOTIDES
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
SUGARS
title SPHINGOGLYCOLIPID ANALOGUES AS THERAPEUTIC AGENTS
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-13T23%3A13%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=HERMANS,%20IAN%20FRANCIS&rft.date=2021-04-20&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECA2880191C%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true